Wisconsin Collaborative for Quality Healthcare

View Our Reports

print this page

Ischemic Vascular Disease: Statin Use Unless Contraindicated This is a measure developed by the Wisconsin Collaborative for Healthcare Quality (WCHQ).

Your Search Results: 29 Clinics in the Bellin Health health system


The results below represent the care of 2,879 patients with coronary and other atherosclerotic vascular disease. Read More About This Measure

Reporting Period:

Sort By Rank | Sort By Name  
Btn Export
ALGOMA NURSING HOME PROGRAM

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH CRIVITZ

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH DAGGETT

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC ALGOMA

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC ASHWAUBENON
N=625
93.60 %
View Historical Data
BELLIN HEALTH FMC ASHWAUBENON IM AND PEDIATRICS
N=197
91.37 %
View Historical Data
BELLIN HEALTH FMC BELLEVUE
N=270
94.81 %
View Historical Data
BELLIN HEALTH FMC BONDUEL

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC BRILLION

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC DE PERE EAST
N=282
94.33 %
View Historical Data
BELLIN HEALTH FMC DE PERE WEST
N=138
92.75 %
View Historical Data
BELLIN HEALTH FMC DENMARK

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC ESCANABA
N=162
88.27 %
View Historical Data
BELLIN HEALTH FMC HOWARD
N=261
91.95 %
View Historical Data
BELLIN HEALTH FMC IRON MOUNTAIN
N=340
96.47 %
View Historical Data
BELLIN HEALTH FMC KEWAUNEE

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC LUXEMBURG

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC MANITOWOC

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC OCONTO

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC OCONTO FALLS
N=130
95.38 %
View Historical Data
BELLIN HEALTH FMC PULASKI

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC SEYMOUR

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC SURING

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC WEBSTER AVE AND CLINICA HISPANA

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH FMC WRIGHTSTOWN

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH MARINETTE
N=474
91.35 %
BELLIN HEALTH MENOMINEE

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH PESHTIGO

The number of patients or providers is too small for
purposes of reliably reporting performance
BELLIN HEALTH STURGEON BAY

The number of patients or providers is too small for
purposes of reliably reporting performance

The American College of Cardiology (ACC) and the American Heart Association (AHA) recommends that high-intensity statin therapy should be initiated or continued as first-line therapy in women and men less than or equal to 75 years of age who have clinical atherosclerotic cardiovascular disease, unless contraindicated.

In November 2013, the ACC and AHA Task Force on Practice Guidelines released updated guidance for the treatment of blood cholesterol. The new recommendations remove treatment targets for LDL-C for the primary or secondary prevention of atherosclerotic cardiovascular disease (ASCVD) and recommend high or moderate intensity statin therapy based on patient risk factors. Four major statin benefit groups were identified and iIndividuals with ASCVD are one of the identified groups.


Disclaimer: Measures reported by WCHQ healthcare organizations represent a specific aspect of care in relation to an evidence-based standard, but are not clinical guidelines and do not establish standards of care.